Acalabrutinib, venetoclax and obinutuzumab as frontline therapy for chronic lymphocytic leukemia: Lancet MD Editorial Team24 Sept 2021 9:00 PM ISTUSA: In a trial led by Matthew S Davids, individuals with undiscovered minimum residual disease (MRD) and untreated chronic lymphocytic leukemia who...
Inclusion of cancer drug in WHO Covid Solidarity trial: CDSCO panel asks ICMR to submit more clarification Farhat Nasim19 Oct 2020 5:14 PM ISTNew Delhi: The expert panel of the Central Drugs Standard Control Organisation (CDSCO) has recently asked the apex medical research body, Indian...
Lymphoma drug acalabrutinib a potential therapy for severe COVID-19 Hina Zahid15 July 2020 8:00 PM ISTHACKENSACK, N.J. — A group of researchers including investigators from John Theurer Cancer Center and Hackensack University Medical Center, made the...
Acalabrutinib - New option to calm cytokine storm in severe Covid 19 Dr. Kamal Kant Kohli6 Jun 2020 12:22 AM ISTAs the Covid 19 pandemic is progressing new and new drugs are being tried to contain the severity of the disease.Dr Mark Roschewski and colleagues...
